Savvywire versus standard LV guidewires during transfemoral TAVI
Official title: SAvvywire for Pacing and Procedural Hemodynamics In Transcatheter Aortic Valve Replacement Evaluation; a Prospective Registry (SAPPHIRE)
Run by Catharina Ziekenhuis Eindhoven · NCT07366671 · Data updated 2026-11-12
For people 50 and older having transfemoral TAVI, researchers will compare the Savvywire and standard LV guidewires to see if the Savvywire improves pacing and procedure-related blood flow.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 50 Years and up |
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | Catharina Ziekenhuis Eindhoven Academic / other |
| Locations | 1 site (Eindhoven, North Brabant) |
| Status | Recruiting |
| Started | January 12, 2026 |
| Main results expected | December 2027 |
| Study ends | March 2028 |
| Registry record updated | March 11, 2026 |
| Trial ID | NCT07366671 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients aged 50 or older who are accepted for transfemoral TAVI (including valve-in-valve and bicuspid cases) and can give written informed consent.
✕Probably not a fit
Patients planned for non-transfemoral TAVI, those with extreme aortic/root or iliofemoral tortuosity or very horizontal aortas, or those unable to consent are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is an observational comparison of routine left-ventricular (LV) guidewires used during transfemoral TAVI procedures, comparing conventional LV guidewires with the newer Savvywire. Procedural details are collected retrospectively after consent is obtained post-procedure, and standard clinical follow-up data are gathered prospectively at about three months. All participants receive usual care; no experimental interventions are assigned. The goal is to document which wires are used and whether the Savvywire adds measurable procedural or hemodynamic value.
Why it matters
Potential benefit: If the Savvywire shows advantages, patients may experience smoother pacing and improved procedural hemodynamics during TAVI, which could reduce complications or procedure time.
How similar studies have gone: Standard LV guidewires are well established and safe, but there is limited published evidence that specialized wires like the Savvywire provide additional pacing or hemodynamic benefits.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 50 years * Accepted for transfemoral TAVI procedure by Heart team and TAVI team * Transfemoral TAVI procedure with balloon-expandable or self-expandable TAVI platform * Ability to understand and the willingness to provide written informed consent * Patients scheduled for valve-in-valve procedures can be included * Patients with bicuspid anatomy can be included Exclusion Criteria: * Patients planned for a non-transfemoral TAVI procedure * Extremely horizontal aorta (aortic root angle \>70 degrees) * Extreme tortuosity at the level of the iliofemoral arteries, abdominal and/or thoracic aorta * Inability to provide informed consent.
Where it's running
-
Catharina Hospital Eindhoven
Eindhoven, North Brabant, Netherlands Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Detecting cardiac amyloidosis in people with severe aortic valve narrowing
This study tests non-invasively whether imaging tests can find heart amyloidosis in patients with severe aortic stenosis who are being evaluated for valve replacement.
-
Feasibility and safety of using a tele-operated robot to guide TAVR with TAVIPILOT software
This study tests whether a tele-operated robotic system can help place a transcatheter heart valve during TAVR in patients aged 65 and older.
-
KONECT RESILIA Aortic Valved Conduit real-world use in adults needing valve and ascending aorta replacement
This study tests how the KONECT RESILIA aortic valved conduit performs in adults needing aortic valve and ascending aorta replacement.
-
Finerenone in patients having TAVI with heart failure
This study tests whether finerenone can help people with heart failure and preserved ejection fraction who are undergoing transcatheter aortic valve implantation.
-
Dexmedetomidine conscious sedation to protect breathing and blood pressure during TAVI
This trial will test whether dexmedetomidine used for conscious sedation during transfemoral TAVI helps reduce breathing problems and unstable blood pressure in patients aged 60 and over.
-
Remote ECG monitoring after TAVI
This compares continuous 30-day remote ECG monitoring to standard short-term monitoring for adults after TAVI to see if it detects rhythm problems earlier.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.